Show simple item record

Mesothelioma stratified therapy (MiST): a phase IIA umbrella trial for accelerating the development of precision medicines

dc.contributor.authorFennell, D
dc.contributor.authorHudka, M
dc.contributor.authorDarlison, L
dc.contributor.authorLord, K
dc.contributor.authorBzura, A
dc.contributor.authorDzialo, J
dc.contributor.authorPritchard, C
dc.contributor.authorHarber, J
dc.contributor.authorTakata, T
dc.contributor.authorPopat, S
dc.contributor.authorKrebs, Matthew G
dc.contributor.authorNolan, L
dc.contributor.authorGreystoke, A
dc.contributor.authorRichards, C
dc.contributor.authorWells-Jordan, P
dc.contributor.authorBranson, A
dc.contributor.authorGaba, A
dc.contributor.authorBhundia, V
dc.contributor.authorScotland, M
dc.contributor.authorMohamed, S
dc.contributor.authorDawson, A
dc.contributor.authorPoille, C
dc.contributor.authorCowley, C
dc.contributor.authorWalter, H
dc.contributor.authorKing, A
dc.contributor.authorThomas, A
dc.date.accessioned2019-12-09T17:08:14Z
dc.date.available2019-12-09T17:08:14Z
dc.date.issued2019en
dc.identifier.citationFennell D, Hudka M, Darlison L, Lord K, Bzura A, Dzialo J, et al. P2.06-02 Mesothelioma Stratified Therapy (MiST): A Phase IIA Umbrella Trial for Accelerating the Development of Precision Medicines. Journal of Thoracic Oncology. 2019;14(10):S755-S6.en
dc.identifier.doi10.1016/j.jtho.2019.08.1620en
dc.identifier.urihttp://hdl.handle.net/10541/622532
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.jtho.2019.08.1620en
dc.titleMesothelioma stratified therapy (MiST): a phase IIA umbrella trial for accelerating the development of precision medicinesen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentLeicester Cancer Research Centre, University of Leicester & University Hospitals of Leicester, Leicester/GBen
dc.identifier.journalJournal of Thoracic Oncologyen
dc.description.noteen


Files in this item

This item appears in the following Collection(s)

Show simple item record